# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Acute myeloid leukemia

Acute Non Lymphoblastic Leukemia
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 11-20 of 654 results.
Micro-transplantation in Elderly Patients With Acute Myeloid Leukemia
Status: Recruiting
Last Changed: Apr 26, 2019
First Received: Feb 20, 2018
Disease(s): Acute Myeloid Leukemia
Intervention(s): HLA-mismatched micro-transplantation after induction chemotherapy
Locations: CHU Estaing, Clermont-Ferrand, France
Centre Hospitalier Universitaire de Grenoble, Grenoble, France
Centre Hospitalier Lyon Sud, Lyon, France
Centre Hospitalier Universitaire de Nancy, Nancy, France
Hôpital de la Pitié-Salpêtrière, Paris, France
... and 2 other locations.
Central Nervous System (CNS) Involvement in Acute Myeloid Leukemia (AML)
Status: Not yet recruiting
Last Changed: Oct 15, 2018
First Received: Jan 25, 2018
Disease(s): Acute Myeloid Leukemia
Intervention(s): Observation of CNS involvement
Locations: Dipartimento di Biotecnologie Cellulari ed Ematologia, "Sapienza", Università di Roma, Roma, Italy
Study to Determine the Efficacy of Uproleselan (GMI-1271) in Combination With Chemotherapy to Treat Relapsed/Refractory Acute Myeloid Leukemia
Status: Recruiting
Last Changed: Nov 04, 2019
First Received: Aug 06, 2018
Disease(s): Acute Myeloid Leukemia
Intervention(s): Uproleselan, Placebo
Locations: UC San Diego Moore Cancer Center, La Jolla, California, United States
UC Davis Comprehensive Cancer Center, Sacramento, California, United States
Emory Winship Cancer Institute, Atlanta, Georgia, United States
Dana Farber Cancer Institute, Boston, Massachusetts, United States
Washington University School of Medicine, Saint Louis, Missouri, United States
... and 21 other locations.
Screening of IDH1 and IDH2 Gene Mutations in Adult Acute Myeloid Leukemia for Possible Targeted Therapy
Status: Recruiting
Last Changed: Apr 20, 2018
First Received: Apr 17, 2018
Disease(s): Acute Myeloid Leukemia
Locations: National Taiwan University Hospital, Taipei, Taiwan
A Randomized Trial of a Combination of Nintedanib/Placebo in Combination With Induction Chemotherapy for Patients With Refractory or First Relapse Acute Myeloid Leukemia
Status: Recruiting
Last Changed: Jan 06, 2020
First Received: Jan 27, 2016
Disease(s): Relapsed/Refractory Acute Myeloid Leukemia
Intervention(s): nintedanib and AML induction, AML induction (placebo)
Locations: Yale University, New Haven, Connecticut, United States
Vanderbilt Ingram Cancer Center, Nashville, Tennessee, United States
A Study of Venetoclax and Alvocidib in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Status: Recruiting
Last Changed: Nov 15, 2019
First Received: Feb 22, 2018
Disease(s): Acute Myeloid Leukemia (AML)
Intervention(s): Venetoclax, Alvocidib
Locations: USC Norris Cancer Center /ID# 170844, Los Angeles, California, United States
UC Irvine /ID# 201093, Orange, California, United States
UC Davis Comprehensive Cancer Center - Main /ID# 170799, Sacramento, California, United States
Sylvester Comprehensive Cancer /ID# 170761, Miami, Florida, United States
Indiana Blood & Marrow Transpl /ID# 170793, Indianapolis, Indiana, United States
... and 11 other locations.
IMGN632 as Monotherapy or With Venetoclax and/or Azacitidine for Patients With CD123-Positive Acute Myeloid Leukemia
Status: Recruiting
Last Changed: Nov 22, 2019
First Received: Sep 11, 2019
Disease(s): Acute Myeloid Leukemia
Intervention(s): Azacitidine, IMGN632, Venetoclax
Locations: Moffitt Cancer Center, Tampa, Florida, United States
MD Anderson, Houston, Texas, United States
Efficacy and Pharmacogenomics of Salvage CLAG-M Chemotherapy in Patients With Relapse/Refractory and Secondary Acute Myeloid Leukemia
Status: Recruiting
Last Changed: Mar 13, 2019
First Received: May 11, 2017
Disease(s): Acute Myeloid Leukemia
Intervention(s): CLAG-M regimen
Locations: Froedtert & the Medical College of Wisconsin, Milwaukee, Wisconsin, United States
A Study to Evaluate Escalating Doses of ASP1235 (AGS62P1) Given as Monotherapy in Subjects With Acute Myeloid Leukemia (AML)
Status: Recruiting
Last Changed: Oct 23, 2019
First Received: Aug 12, 2016
Disease(s): Acute Myeloid Leukemia
Intervention(s): ASP1235
Locations: Site US00006, Duarte, California, United States
Site US00003, Baltimore, Maryland, United States
Site US00007, Boston, Massachusetts, United States
Site US00009, Boston, Massachusetts, United States
Site US00004, New York, New York, United States
... and 3 other locations.
A Study of ASTX660 as a Single Agent and in Combination With ASTX727 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia (AML)
Status: Not yet recruiting
Last Changed: Nov 08, 2019
First Received: Nov 07, 2019
Disease(s): Acute Myeloid Leukemia
Intervention(s): ASTX660, ASTX727